martes, 10 de noviembre de 2026

PepGen says early trial for muscular dystrophy drug looks promising Infusion for a common dystrophy form is one of several in development By Jason MastNov. 10, 2026 General Assignment Reporter

https://www.statnews.com/2026/11/10/muscular-dystrophy-dm1-pepgen-pgn-edodm1-early-results/

No hay comentarios:

Publicar un comentario